cholestyramine resin has been researched along with quinuclidines in 1 studies
| Studies (cholestyramine resin) | Trials (cholestyramine resin) | Recent Studies (post-2010) (cholestyramine resin) | Studies (quinuclidines) | Trials (quinuclidines) | Recent Studies (post-2010) (quinuclidines) |
|---|---|---|---|---|---|
| 2,669 | 342 | 190 | 2,567 | 453 | 991 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Inagaki, O; Kakuta, H; Moritani, H; Shikama, H; Ugawa, T | 1 |
1 other study(ies) available for cholestyramine resin and quinuclidines
| Article | Year |
|---|---|
YM-53601, a novel squalene synthase inhibitor, suppresses lipogenic biosynthesis and lipid secretion in rodents.
Topics: Animals; Anticholesteremic Agents; Cholesterol; Cholestyramine Resin; Cricetinae; Farnesyl-Diphosphate Farnesyltransferase; Fatty Acids, Nonesterified; Lipoprotein Lipase; Liver; Male; Mesocricetus; Polyethylene Glycols; Protamines; Quinuclidines; Rats; Rats, Sprague-Dawley; Triglycerides | 2003 |